The Histone Demethylase KDM1A Sustains the Oncogenic Potential of MLL-AF9 Leukemia Stem Cells

被引:474
作者
Harris, William J. [1 ]
Huang, Xu [1 ]
Lynch, James T. [1 ]
Spencer, Gary J. [1 ]
Hitchin, James R. [2 ]
Li, Yaoyong [3 ]
Ciceri, Filippo [1 ]
Blaser, Julian G. [1 ]
Greystoke, Brigit F. [1 ]
Jordan, Allan M. [2 ]
Miller, Crispin J. [3 ]
Ogilvie, Donald J. [2 ]
Somervaille, Tim C. P. [1 ]
机构
[1] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Leukaemia Biol Lab, Manchester M20 4BX, Lancs, England
[2] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Drug Discovery Unit, Manchester M20 4BX, Lancs, England
[3] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Appl Computat Biol & Bioinformat Grp, Manchester M20 4BX, Lancs, England
关键词
ACUTE MYELOID-LEUKEMIA; MIXED-LINEAGE LEUKEMIA; EMBRYONIC STEM; DEVELOPMENTAL REGULATORS; GENE ACTIVATION; LSD1; CHROMATIN; TRANSCRIPTION; COMPLEXES; MAINTENANCE;
D O I
10.1016/j.ccr.2012.03.014
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Using a mouse model of human MLL-AF9 leukemia, we identified the lysine-specific demethylase KDM1A (LSD1 or AOF2) as an essential regulator of leukemia stem cell (LSC) potential. KDM1A acts at genomic loci bound by MLL-AF9 to sustain expression of the associated oncogenic program, thus preventing differentiation and apoptosis. In vitro and in vivo pharmacologic targeting of KDM1A using tranylcypromine analogs active in the nanomolar range phenocopied Kdm1a knockdown in both murine and primary human AML cells exhibiting MLL translocations. By contrast, the clonogenic and repopulating potential of normal hematopoietic stem and progenitor cells was spared. Our data establish KDM1A as a key effector of the differentiation block in MLL leukemia, which may be selectively targeted to therapeutic effect.
引用
收藏
页码:473 / 487
页数:15
相关论文
共 39 条
[1]   An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors [J].
Ben-Porath, Ittai ;
Thomson, Matthew W. ;
Carey, Vincent J. ;
Ge, Ruping ;
Bell, George W. ;
Regev, Aviv ;
Weinberg, Robert A. .
NATURE GENETICS, 2008, 40 (05) :499-507
[2]   MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L [J].
Bernt, Kathrin M. ;
Zhu, Nan ;
Sinha, Amit U. ;
Vempati, Sridhar ;
Faber, Joerg ;
Krivtsov, Andrei V. ;
Feng, Zhaohui ;
Punt, Natalie ;
Daigle, Amanda ;
Bullinger, Lars ;
Pollock, Roy M. ;
Richon, Victoria M. ;
Kung, Andrew L. ;
Armstrong, Scott A. .
CANCER CELL, 2011, 20 (01) :66-78
[3]   Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes [J].
Biswas, Debabrata ;
Milne, Thomas A. ;
Basrur, Venkatesha ;
Kim, Jaehoon ;
Elenitoba-Johnson, Kojo S. J. ;
Allis, C. David ;
Roeder, Robert G. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (38) :15751-15756
[4]   Polycomb complexes repress developmental regulators in murine embryonic stem cells [J].
Boyer, LA ;
Plath, K ;
Zeitlinger, J ;
Brambrink, T ;
Medeiros, LA ;
Lee, TI ;
Levine, SS ;
Wernig, M ;
Tajonar, A ;
Ray, MK ;
Bell, GW ;
Otte, AP ;
Vidal, M ;
Gifford, DK ;
Young, RA ;
Jaenisch, R .
NATURE, 2006, 441 (7091) :349-353
[5]   Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia [J].
Dawson, Mark A. ;
Prinjha, Rab K. ;
Dittmann, Antje ;
Giotopoulos, George ;
Bantscheff, Marcus ;
Chan, Wai-In ;
Robson, Samuel C. ;
Chung, Chun-wa ;
Hopf, Carsten ;
Savitski, Mikhail M. ;
Huthmacher, Carola ;
Gudgin, Emma ;
Lugo, Dave ;
Beinke, Soren ;
Chapman, Trevor D. ;
Roberts, Emma J. ;
Soden, Peter E. ;
Auger, Kurt R. ;
Mirguet, Olivier ;
Doehner, Konstanze ;
Delwel, Ruud ;
Burnett, Alan K. ;
Jeffrey, Phillip ;
Drewes, Gerard ;
Lee, Kevin ;
Huntly, Brian J. P. ;
Kouzarides, Tony .
NATURE, 2011, 478 (7370) :529-533
[6]   Mapping and analysis of chromatin state dynamics in nine human cell types [J].
Ernst, Jason ;
Kheradpour, Pouya ;
Mikkelsen, Tarjei S. ;
Shoresh, Noam ;
Ward, Lucas D. ;
Epstein, Charles B. ;
Zhang, Xiaolan ;
Wang, Li ;
Issner, Robbyn ;
Coyne, Michael ;
Ku, Manching ;
Durham, Timothy ;
Kellis, Manolis ;
Bernstein, Bradley E. .
NATURE, 2011, 473 (7345) :43-U52
[7]  
Fathi A. T., 2012, ADV HEMATOL
[8]   Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study [J].
Fenaux, Pierre ;
Mufti, Ghulam J. ;
Hellstrom-Lindberg, Eva ;
Santini, Valeria ;
Finelli, Carlo ;
Giagounidis, Aristoteles ;
Schoch, Robert ;
Gattermann, Norbert ;
Sanz, Guillermo ;
List, Alan ;
Gore, Steven D. ;
Seymour, John F. ;
Bennett, John M. ;
Byrd, John ;
Backstrom, Jay ;
Zimmerman, Linda ;
McKenzie, David ;
Beach, C. L. ;
Silverman, Lewis R. .
LANCET ONCOLOGY, 2009, 10 (03) :223-232
[9]   Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors [J].
Garcia-Bassets, Ivan ;
Kwon, Young-Soo ;
Telese, Francesca ;
Prefontaine, Gratien G. ;
Hutt, Kasey R. ;
Cheng, Christine S. ;
Ju, Bong-Gun ;
Ohgi, Kenneth A. ;
Wang, Jianxun ;
Escoubet-Lozach, Laure ;
Rose, David W. ;
Glass, Christopher K. ;
Fu, Xiang-Dong ;
Rosenfeld, Michael G. .
CELL, 2007, 128 (03) :505-518
[10]   Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia [J].
Goardon, Nicolas ;
Marchi, Emanuele ;
Atzberger, Ann ;
Quek, Lynn ;
Schuh, Anna ;
Soneji, Shamit ;
Woll, Petter ;
Mead, Adam ;
Alford, Kate A. ;
Rout, Raj ;
Chaudhury, Salma ;
Gilkes, Amanda ;
Knapper, Steve ;
Beldjord, Kheira ;
Begum, Suriya ;
Rose, Susan ;
Geddes, Nicola ;
Griffiths, Mike ;
Standen, Graham ;
Sternberg, Alexander ;
Cavenagh, Jamie ;
Hunter, Hannah ;
Bowen, David ;
Killick, Sally ;
Robinson, Lisa ;
Price, Andrew ;
Macintyre, Elizabeth ;
Virgo, Paul ;
Burnett, Alan ;
Craddock, Charles ;
Enver, Tariq ;
Jacobsen, Sten Eirik W. ;
Porcher, Catherine ;
Vyas, Paresh .
CANCER CELL, 2011, 19 (01) :138-152